HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -20.24 Million USD | -2.97% |
| 2021 | -15.35 Million USD | -8.89% |
| 2020 | -18.27 Million USD | -8.2% |
| 2019 | -17.24 Million USD | -18.79% |
| 2018 | -15.09 Million USD | 21.14% |
| 2017 | -16.4 Million USD | 26.99% |
| 2016 | -22.68 Million USD | -24.39% |
| 2015 | -19 Million USD | -57.81% |
| 2014 | -12.75 Million USD | -8.44% |
| 2013 | -11.24 Million USD | -10.55% |
| 2012 | -12.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | - USD | 100.0% |
| 2023 Q1 | -5.01 Million USD | -13.4% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | -4.42 Million USD | -5.74% |
| 2022 Q2 | -5.67 Million USD | 6.36% |
| 2022 Q1 | -6.06 Million USD | -27.11% |
| 2022 Q3 | -4.18 Million USD | 26.36% |
| 2022 FY | - USD | -2.97% |
| 2021 Q2 | -3.89 Million USD | 10.98% |
| 2021 Q3 | -4.02 Million USD | -3.39% |
| 2021 FY | - USD | -8.89% |
| 2021 Q4 | -4.76 Million USD | -18.37% |
| 2021 Q1 | -4.37 Million USD | -18.12% |
| 2020 Q4 | -3.7 Million USD | 22.74% |
| 2020 Q3 | -4.79 Million USD | -1.38% |
| 2020 Q2 | -4.73 Million USD | -0.1% |
| 2020 Q1 | -4.72 Million USD | -29.14% |
| 2020 FY | - USD | -8.2% |
| 2019 FY | - USD | -18.79% |
| 2019 Q4 | -3.66 Million USD | 9.61% |
| 2019 Q3 | -4.04 Million USD | 2.08% |
| 2019 Q2 | -4.13 Million USD | 13.02% |
| 2019 Q1 | -4.75 Million USD | -209.9% |
| 2018 FY | - USD | 21.14% |
| 2018 Q4 | -1.53 Million USD | 63.99% |
| 2018 Q1 | -4.73 Million USD | -181.55% |
| 2018 Q2 | -4.06 Million USD | 14.2% |
| 2018 Q3 | -4.26 Million USD | -4.86% |
| 2017 Q4 | -1.68 Million USD | 64.76% |
| 2017 FY | - USD | 26.99% |
| 2017 Q1 | -5.12 Million USD | 2.29% |
| 2017 Q2 | -5.19 Million USD | -1.52% |
| 2017 Q3 | -4.77 Million USD | 8.18% |
| 2016 Q3 | -5.63 Million USD | 5.06% |
| 2016 Q2 | -5.94 Million USD | 5.32% |
| 2016 Q1 | -6.27 Million USD | -17.46% |
| 2016 FY | - USD | -24.39% |
| 2016 Q4 | -5.24 Million USD | 7.06% |
| 2015 FY | - USD | -57.81% |
| 2015 Q1 | -3.99 Million USD | -22.64% |
| 2015 Q4 | -5.34 Million USD | -15.99% |
| 2015 Q3 | -4.6 Million USD | -2.45% |
| 2015 Q2 | -4.49 Million USD | -12.42% |
| 2014 FY | - USD | -8.44% |
| 2014 Q3 | -3.02 Million USD | 12.43% |
| 2014 Q2 | -3.45 Million USD | -31.03% |
| 2014 Q1 | -2.63 Million USD | -4.81% |
| 2014 Q4 | -3.25 Million USD | -7.87% |
| 2013 Q4 | -2.51 Million USD | 4.48% |
| 2013 FY | - USD | -10.55% |
| 2013 Q2 | -3.24 Million USD | 0.0% |
| 2013 Q3 | -2.63 Million USD | 18.97% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -1640.538% |
| Arrayit Corporation | -3.07 Million USD | -557.758% |
| Atlantic International Corp. | -5.38 Million USD | -275.586% |
| Biocept, Inc. | -30.24 Million USD | 33.063% |
| Bioqual, Inc. | 3.03 Million USD | 767.574% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -2572.713% |
| DermTech, Inc. | -97.89 Million USD | 79.322% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.695% |
| iMD Companies, Inc. | -154.65 Thousand USD | -12988.445% |
| IDenta Corp. | 71.58 Thousand USD | 28376.723% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 627.559% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 52419.612% |
| InVitro International | 6680.00 USD | 303130.808% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -272.378% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -166724.279% |
| Medical Imaging Corp. | -896.74 Thousand USD | -2157.334% |
| NovelStem International Corp. | -3.78 Million USD | -434.694% |
| Optigenex Inc. | -1.18 Million USD | -1605.743% |
| PharmChem, Inc. | 1.05 Million USD | 2020.883% |
| Proteome Sciences plc | -1.13 Million USD | -1680.339% |
| Response Genetics, Inc | -19.66 Million USD | -2.931% |
| Rennova Health, Inc. | -234.81 Thousand USD | -8520.598% |
| RushNet, Inc. | -614.85 Thousand USD | -3192.249% |
| ScreenPro Security Inc. | -3.43 Million USD | -489.319% |
| Stella Diagnostics Inc. | -5.7 Million USD | -254.669% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -97.1% |
| Todos Medical Ltd. | -9.39 Million USD | -115.483% |